Price wars are still on but... 4 stocks from diagnostics sector have upside potential of up to 26%
In the last five years, the diagnostic segment of the healthcare sector has seen many ups and downs. During Covid, diagnostic players were overloaded with work and then came the price wars which some new tech companies brought on the table. The price war was essentially started to grab both, market and mind share. While the price war is still on in some segments, there is a possibility that its intensity may come down. The reason, new companies have burnt enough cash and large physical-only players have also made some inroads into digital channels for customer acquisition and also part deliver...
Source: indiatimes.com
